3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Classical hematology
2
Conditions
Myelodysplastic Syndromes
100
Leukemia, Myeloid, Acute
93
Precursor Cell Lymphoblastic Leukemia-Lymphoma
74
Myeloproliferative Disorders
71
Multiple Myeloma
65
Lymphoma, Non-Hodgkin
62
Leukemia
62
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Leukemia, Lymphocytic, Chronic, B-Cell
58
Hodgkin Disease
58
Primary Myelofibrosis
52
Lymphoma, Mantle-Cell
45
Lymphoma, Large B-Cell, Diffuse
42
Burkitt Lymphoma
42
Lymphoma, Follicular
41
Leukemia, Myeloid, Chronic-Phase
40
Lymphoma, B-Cell, Marginal Zone
39
Lymphoma
39
Lymphoma, Large-Cell, Immunoblastic
38
Congenital Abnormalities
37
Lymphoma, T-Cell, Cutaneous
35
Leukemia, Myeloid, Accelerated Phase
35
Sezary Syndrome
32
Mycosis Fungoides
32
Leukemia, Myelomonocytic, Chronic
32
Blast Crisis
32
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
28
Pdgfra-Associated Chronic Eosinophilic Leukemia
27
Leukemia, Neutrophilic, Chronic
27
Neoplasms, Plasma Cell
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Severe Combined Immunodeficiency
×
Myeloid
×
Clear all
NCT05298930
2024-08-21
EVAADE
Centre Leon Berard
Phase NA
Completed
15 enrolled
NCT04331483
2022-02-28
EVAADE
Centre Leon Berard
Phase NA
Withdrawn